source
- Full-Life Technologies secures $150M Series D financingFull-Life Technologies announced it has raised $150 million in a Series D financing round, comprising $110 million in the main tranche and an additional $40 million. The capital is intended to adv…
- Relay Therapeutics reports promising Phase 2 results for zovegalisib; Eli Lilly leads R&D performance rankingRelay Therapeutics announced positive Phase 2 data for its experimental drug zovegalisib, which targets rare diseases that cause abnormal blood vessel development. The company said the results were…